Neuburgh Advisers’s Pediatrix Medical MD Stock Holding History

Neuburgh Advisers’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.26M	Sell	55,528 -17,490	-24%	-$399K	0.04%	288
2019 Q2	$1.84M	Sell	73,018 -16,522	-18%	-$444K	0.06%	243
2019 Q1	$2.43M	Buy	89,540 +11,660	+15%	+$391K	0.08%	192
2018 Q4	$2.57M	Buy	77,880 +7,854	+11%	+$316K	0.1%	168
2018 Q3	$3.27M	Sell	70,026 -300,014	-81%	-$13.8M	0.11%	173
2018 Q2	$16M	Sell	370,040 -28,578	-7%	-$1.37M	0.53%	47
2018 Q1	$22.2M	Sell	398,618 -122,188	-23%	-$6.7M	0.78%	33
2017 Q4	$27.8M	Sell	520,806 -59,312	-10%	-$2.8M	1%	23
2017 Q3	$25M	Buy	580,118 +3,036	+0.5%	+$144K	0.93%	29
2017 Q2	$34.8M	Buy	577,082 +22,308	+4%	+$1.32M	1.32%	17
2017 Q1	$38.5M	Buy	554,774 +10,890	+2%	+$756K	1.52%	12
2016 Q4	$36.3M	Buy	+543,884	New	+$35.4M	1.63%	11

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Neuburgh Advisers's MD Position: Q3 2019 in Review

Neuburgh Advisers reduced its Pediatrix Medical (MD) stake by 24% in Q3 2019, selling an estimated $399K and leaving 55,528 shares worth $1.26M. The position accounts for 0.04% of the portfolio, ranked #288.

Neuburgh Advisers first reported a position in MD in Q4 2016 and has held it in 12 quarters since. The position peaked at $38.5M in Q1 2017. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

Neuburgh Advisers held 55,528 shares of Pediatrix Medical worth $1.26M as of Q3 2019.
Neuburgh Advisers sold 17,490 Pediatrix Medical shares in Q3 2019, an estimated $399K.
Pediatrix Medical made up 0.04% of Neuburgh Advisers's portfolio in Q3 2019, its #288 holding.
Neuburgh Advisers first reported a position in Pediatrix Medical in Q4 2016 and has held it in 12 quarters since.
Neuburgh Advisers's Pediatrix Medical position peaked at $38.5M in Q1 2017.
223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.